The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus (Q44515970)

3 December 2017

The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus (English)

1 reference

3 December 2017

0 references

0 references

1 reference

1 reference

1

1 reference

3 December 2017

2

1 reference

3 December 2017

Leonardina Ciccarelli

series ordinal

5

object named as

Leonardina Ciccarelli

1 reference

3 December 2017

6

Roberto Fogari

1 reference

3 December 2017

Antonio Vittorino Gaddi

series ordinal

3

object named as

Antonio Gaddi

1 reference

3 December 2017

4

Amedeo Mugellini

1 reference

3 December 2017

language of work or name

1 reference

1 May 2003

1 reference

3 December 2017

Clinical Therapeutics

1 reference

3 December 2017

25

1 reference

3 December 2017

1429-1439

1 reference

3 December 2017

5

1 reference

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980130-3

7 January 2021

Lipoprotein(a) as a risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980130-3

7 January 2021

Is lipoprotein(a) a predictor for survival in patients with established coronary artery disease? Results from a prospective patient cohort study in northern Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980130-3

7 January 2021

Elevated serum lipoprotein(a) level is an independent marker of severity of thoracic aortic atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980130-3

7 January 2021

Relation of lipid and lipoprotein(a) to ischaemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980130-3

7 January 2021

Type of diabetes and waist-hip ratio are important determinants of serum lipoprotein (a) levels in diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980130-3

7 January 2021

Influence of lipoprotein(a) on restenosis after femoropopliteal percutaneous transluminal angioplasty in Type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980130-3

7 January 2021

Extended-release niacin treatment of the atherogenic lipid profile and lipoprotein(a) in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980130-3

7 January 2021

Determination of total serum insulin (IRI) in insulin-treated diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980130-3

7 January 2021

The Glycosylation of Hemoglobin: Relevance to Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980130-3

7 January 2021

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980130-3

7 January 2021

Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980130-3

7 January 2021

L-Carnitine effects on chemical composition of plasma lipoproteins of rabbits fed with normal and high cholesterol diets

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980130-3

7 January 2021

Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980130-3

7 January 2021

Lipid-lowering effect of carnitine in patients with type-IV hyperlipoproteinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980130-3

7 January 2021

Effect of L-carnitine supplementation on lipid parameters in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980130-3

7 January 2021

Effect of L-carnitine supplementation in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980130-3

7 January 2021

Molecular genetics of lipoprotein (a): new pieces to the puzzle

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980130-3

7 January 2021

Effects of estrus cycle, ovariectomy, and treatment with estrogen, tamoxifen, and progesterone on apolipoprotein(a) gene expression in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980130-3

7 January 2021

Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980130-3

7 January 2021

CI-1011 lowers lipoprotein(a) and plasma cholesterol concentrations in chow-fed cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980130-3

7 January 2021

Carnitine deficiency in diabetes mellitus complications

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980130-3

7 January 2021

Diabetic cardiomyopathy and carnitine deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980130-3

7 January 2021

10.1016/S0149-2918(03)80130-3

Identifiers

DOI

1 reference

3 December 2017

1 reference